Acino International AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5165
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women’s health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The company’s drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino International AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Private Equity 17
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Partnerships 18
Acino International Enters into Distribution Agreement with Merck 18
Licensing Agreements 19
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 19
Asset Transactions 20
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 20
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 21
Acquisition 22
Acino Pharma Acquires Litha Healthcare from Endo International 22
Acino Pharma Acquires Pharma Start 23
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 24
Acino International AG – Key Competitors 26
Acino International AG – Key Employees 27
Acino International AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Corporate Communications 30
Jun 04, 2018: Steffen Saltofte appointed CEO Acino Group 30
Feb 15, 2017: Appointment of Mario Ricard as COO and member of the Executive Committee 31
Jan 23, 2017: Resignation of Barthold Piening, Chief Operations Officer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Acino International Enters into Distribution Agreement with Merck 18
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 19
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 20
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 21
Acino Pharma Acquires Litha Healthcare from Endo International 22
Acino Pharma Acquires Pharma Start 23
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 24
Acino International AG, Key Competitors 26
Acino International AG, Key Employees 27
Acino International AG, Subsidiaries 28

List of Figures
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Acino International AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Welltower Inc:企業のM&A・事業提携・投資動向
    Welltower Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Welltower Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Exor N.V
    Exor N.V - Strategy, SWOT and Corporate Finance Report Summary Exor N.V - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Zion Oil & Gas Inc (ZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Papeles y Cartones de Europa SA:企業の戦略・SWOT・財務情報
    Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report Summary Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • National Institute of Agricultural Research-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various co …
  • Nufarm Ltd (NUF):企業の財務・戦略的SWOT分析
    Nufarm Ltd (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • North Central Electric Cooperative, Inc.:発電所・企業SWOT分析
    North Central Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informa …
  • Meridian Energy Ltd (MEL):電力:M&Aディール及び事業提携情報
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …
  • Standex International Corp:企業の戦略・SWOT・財務情報
    Standex International Corp - Strategy, SWOT and Corporate Finance Report Summary Standex International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rebiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases hea …
  • Melbana Energy Ltd (MAY):石油・ガス:M&Aディール及び事業提携情報
    Summary Melbana Energy Ltd (Melbana), formerly MEO Australia Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of oil and gas properties. Its projects include Cuba – Block 9 PSC, Taranaki Basin, Petrel Sub-Basin Exploration, T …
  • Alkermes Plc (ALKS)-製薬・医療分野:企業M&A・提携分析
    Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspen …
  • Corcept Therapeutics Inc (CORT):製薬・医療:M&Aディール及び事業提携情報
    Summary Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic an …
  • IREN SpA (IRE):電力:M&Aディール及び事業提携情報
    Summary IREN SpA (IREN) is a multi-utility. It generates and sells electricity and thermal energy; sells gas; collects, selects, recovers and disposes urban waste; and provides integrated water services, and public lighting, global services and other services. The company produces power in hydro, th …
  • Iberia Lineas Aereas De Espana, Sa
    Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bdo Unibank Inc
    Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Centerra Gold Inc.
    Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chevron Corp (CVX):石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆